Department of Oral and Maxillofacial Surgery, Technische Universität München, Klinikum Rechts der Isar, Munich, Germany.
Ann Surg Oncol. 2010 Jan;17(1):287-95. doi: 10.1245/s10434-009-0758-0. Epub 2009 Oct 20.
The purpose of this study was to examine whether or not immediate microvascular free flap reconstruction influences survival among treated patients suffering from oral squamous cell carcinoma (OSCC), controlling for demographic, clinical, and tumor characteristics.
773 patients with OSCC were treated with curative intent. Two hundred and seventy-four patients were immediately reconstructed using free microsurgical flaps. All measures were collected by chart abstraction. Kaplan-Meier plots and univariate log-rank test and multivariate Cox proportional hazards regression models were used to determine the association between possible predictor variables and survival time. In addition, a randomized matched-pair analysis was conducted to compensate different patient cohorts.
After controlling for age, tumor stage, nodal stage, and tumor grade, which were independent and dependent predictors of survival, microsurgical free flap reconstruction was associated with survival [hazard ratio (HR) = 0.66, P < 0.001, 95% confidence interval (CI), 0.52 to 0.83]. In the randomized matched-pair analysis this effect became more evident (HR = 0.58, P < 0.001, 95% CI, 0.44 to 0.75). Controlling for extent of tumor, only T3 and T4 tumors were significantly associated with survival (P < 0.001, HR = 0.46, 95% CI, 0.31 to 0.69) when the area of defect was reconstructed, whereas in T1 and T2 tumors no significance was noted (P = 0.08, HR = 0.74, 95% CI, 0.53 to 1.04).
Reconstruction of defects, especially in patients presenting with higher tumor stages, is not associated with shorter overall survival rates, as revealed in this study, and should be considered when functional deficits due to tumor ablation can be expected postoperatively.
本研究旨在探讨接受治疗的口腔鳞状细胞癌(OSCC)患者是否接受即刻微血管游离皮瓣重建会影响生存率,同时控制人口统计学、临床和肿瘤特征。
773 例 OSCC 患者接受了根治性治疗。274 例患者接受了游离显微皮瓣即刻重建。所有指标均通过图表摘录收集。使用 Kaplan-Meier 图和单变量对数秩检验和多变量 Cox 比例风险回归模型来确定可能的预测变量与生存时间之间的关联。此外,还进行了随机匹配对分析以补偿不同的患者队列。
在控制年龄、肿瘤分期、淋巴结分期和肿瘤分级等独立和依赖的生存预测因素后,显微游离皮瓣重建与生存相关[风险比(HR)=0.66,P<0.001,95%置信区间(CI)0.52 至 0.83]。在随机匹配对分析中,这种影响更加明显(HR=0.58,P<0.001,95%CI,0.44 至 0.75)。当控制肿瘤范围时,只有 T3 和 T4 肿瘤与生存显著相关(P<0.001,HR=0.46,95%CI,0.31 至 0.69),当重建缺损面积时,T1 和 T2 肿瘤则无显著意义(P=0.08,HR=0.74,95%CI,0.53 至 1.04)。
正如本研究所示,重建缺损,尤其是在肿瘤分期较高的患者中,与总体生存率降低无关,并且在预期术后因肿瘤消融而导致功能缺陷时应考虑进行重建。